[18F]FAPI-74

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug Name[18F]FAPI-74
Drug Alias Name[18F] aluminium fluorine ((S)-2,2'(7- (2-(4-(3-(4-(2-(2- cyanopyrrolidin-1-yl)-2 oxoethylcarbamoyl)quinolin-6-yloxy) propyl)piperazin-1-yl)-2-oxoethyl)-1,4,7- triazonane-1,4-diyl)diacetic acidFAPI-74[18F]FAPI-74Fluor-18-FAPI-74F-18]FAPI-74
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4] 
Mechanisms of ActionPositron-emission tomography enhancersFibroblast activation protein alpha inhibitors
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsDermatomyositisUrinary Bladder NeoplasmsOvarian Neoplasms +[17] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Heidelberg
China Registration ClassN/A

Develop Information

Active CompaniesSociety Of Nuclear Medicine And Molecular ImagingGE HealthCare Technologies IncStanford University +[6] 
Inactive CompaniesN/A
Active IndicationsDermatomyositisUrinary Bladder NeoplasmsOvarian Neoplasms +[17] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A